Nxera Pharma & Santhera Pharmaceuticals
6 shared events · Importance 3 · Last updated Jun 02, 2026
Nxera Pharma is a licensee of Santhera Pharmaceuticals, having acquired exclusive rights to develop, manufacture, and commercialize vamorolone in Japan, South Korea, Australia, and New Zealand, and also holds a minor equity stake in Santhera.
Track how Nxera Pharma and Santhera Pharmaceuticals interact across events, view sentiment trends, and discover connected entities.
Open Dashboard